![Class of 2021 celebrated for courage, resilience: “You have shone brightly” – Lawrence University News Class of 2021 celebrated for courage, resilience: “You have shone brightly” – Lawrence University News](https://blogs.lawrence.edu/news/files/2021/06/Commencement-Raymond-new.jpg)
Class of 2021 celebrated for courage, resilience: “You have shone brightly” – Lawrence University News
![The threat of Omicron continues as new COVID-19 cases soar to highest on record | News | mtstandard.com The threat of Omicron continues as new COVID-19 cases soar to highest on record | News | mtstandard.com](https://bloximages.chicago2.vip.townnews.com/mtstandard.com/content/tncms/assets/v3/editorial/0/91/09118409-e2fe-57be-b704-ab2fcfd17ea2/61cce114bf742.preview.jpg?crop=1763%2C926%2C0%2C124&resize=438%2C230&order=crop%2Cresize)
The threat of Omicron continues as new COVID-19 cases soar to highest on record | News | mtstandard.com
![Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity | Leukemia Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-020-01068-2/MediaObjects/41375_2020_1068_Fig1_HTML.png)
Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity | Leukemia
![Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study | Bone Marrow Transplantation Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-020-01178-6/MediaObjects/41409_2020_1178_Fig1_HTML.png)
Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study | Bone Marrow Transplantation
![Frontiers | Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series | Oncology Frontiers | Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series | Oncology](https://www.frontiersin.org/files/Articles/521092/fonc-10-00702-HTML-r1/image_m/fonc-10-00702-g001.jpg)